SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-22-008912
Filing Date
2022-02-11
Accepted
2022-02-11 16:49:10
Documents
1
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 5 SUBMISSION doc5.html 5  
1 FORM 5 SUBMISSION doc5.xml 5 4794
  Complete submission text file 0001209191-22-008912.txt   6387
Mailing Address 345 PARK AVENUE SOUTH 3RD FLOOR NEW YORK NY 10010
Business Address 345 PARK AVENUE SOUTH 3RD FLOOR NEW YORK NY 10010 646-844-0337
Protara Therapeutics, Inc. (Issuer) CIK: 0001359931 (see all company filings)

IRS No.: 204580525 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O ARTARA THERAPEUTICS,INC. 1 LITTLE WEST 12TH STREET NEW YORK NY 10014
Business Address
Shefferman Jesse (Reporting) CIK: 0001799167 (see all company filings)

Type: 5 | Act: 34 | File No.: 001-36694 | Film No.: 22622089